The stock climbed nearly 7% to close Wednesday's trading at $8.01. Onyx Pharmaceuticals, Inc. (ONXX) on Wednesday announced it is offering 4.4 million shares of its common stock in an underwritten public offering - with the gross …
Now that Amgen has acquired cancer drug specialist Onyx Pharmaceutical (ONXX), sales of Onyx ... up one of your stocks? For more stock grades, please visit my Portfolio Grader website! Article printed from InvestorPlace Media, …
Merrill Lynch has a $123 target for the stock, and the consensus is at $120. Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) recently announced positive results from the phase III DECISION study on Nexavar (sorafenib) tablets in …
Apart from rumors regarding Alexion Pharma’s potential takeover, Onyx Pharmaceuticals, Inc. (ONXX) is another stock in the biopharma space which is in the news as an acquisition target. Alexion Pharma currently carries a Zacks Rank #3 …
In the next few weeks, investors in cancer drug maker Onyx Pharmaceuticals (ONXX) will find out if the company will get a speedy review of its experimental treatment carflizomib for multiple myeloma. Some analysts are skeptical and -- …
Among leading biotech and emerging pharmaceutical companies, Celgene (NASDAQ: CELG), Onyx Pharmaceuticals (NASDAQ: ONXX) and Vertex Pharmaceuticals ... surveyed by Thomson/First Call, 13 rate the stock at Strong Buy …
Onyx Pharmaceuticals (ONXX) has been one of the year's hottest stocks, more than doubling in price over the past year. Yet Deutsche Bank analyst Navdeep Singh thinks the stock has plenty of room to run, given the prospects for the …
Onyx Pharmaceuticals (ONXX) will visit the NASDAQ MarketSite in New York City's Times Square. In honor of the …
Ford’s stock shot up 2.8 percent to close at $16.18 while GM’s ... Sources said Pfizer Inc (PFE.N) and Novartis AG NOVN.VX may make preliminary bids for Onyx Pharmaceuticals Inc ONXX.O. On Sunday, Onyx turned down a …
U.S. stock futures were slightly lower early Monday as investors ... Shares of Amgen (AMGN) rose 4% after it agreed to buy Onyx Pharmaceuticals (ONXX) for $10.4 billion, in a deal that will give Amgen access to a wide range of cancer …